Category Archives: Industry Updates

Evidence Spotlight: New AJG Study Reinforces the Role of Carbohydrate Malabsorption Breath Testing in DGBI

A recent study and editorial in The American Journal of Gastroenterology (AJG) revisit a question that sits at the heart of modern functional GI care: When patients with disorders of gut–brain interaction (DGBI) say they’re “intolerant” to certain carbohydrates, how often is that backed by objective malabsorption—and does it matter clinically? The answer from this work: carbohydrate malabsorption…

New Study Validates the Clinical Utility of Hydrogen & Methane Breath Testing for SIBO

A newly published study from Swedish clinical researchers further confirms the diagnostic value of hydrogen and methane breath testing (HMBT) for Small Intestinal Bacterial Overgrowth (SIBO)—supporting the core science behind CDI’s non-invasive testing model. The 2025 study, Refined Lactulose Hydrogen Breath Test for Small Intestinal Bacterial Overgrowth Diagnosis Based on a Survey Among Experts, analyzed data from…

Why Symptoms Alone Aren’t Enough—The Critical Role of Breath Testing in Functional GI Diagnostics

As functional GI disorders, such as Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and carbohydrate malabsorption, continue to challenge clinicians due to symptom overlap and diagnostic ambiguity, new research underscores an important truth: symptoms and history alone are not reliable predictors of breath test outcomes. A large-scale 2024 study conducted by our research…

The IMO Landscape: Insights from Breath Testing Research and Clinical Practice

Breath testing for methane provides indispensable insights into the presence and severity of Intestinal Methanogen Overgrowth, highlighting its critical role in modern gastroenterology. As research advances and clinical practices evolve, breath testing remains a cornerstone in diagnosing and managing IMO, offering a more straightforward path towards optimal patient care.   Intestinal Methanogen Overgrowth (IMO), formally…

Breath Testing: A Reliable Compass in Navigating SIBO Diagnosis and Post-Treatment Evaluation

In the intricate journey of Small Intestinal Bacterial Overgrowth (SIBO) diagnosis and treatment, breath testing has become a beacon of clarity and a distinguishing factor in better managing these cases. A recent study published in the Journal of Neurogastroenterology and Motility reinforces the pivotal role of breath tests in diagnosing SIBO and as a crucial…

Navigating the New ICD-10 Codes for SIBO and IMO: A Comprehensive Guide

After years of industry advocacy with the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), healthcare providers now have dedicated ICD-10 codes for intestinal microbial overgrowth and its subsets, including Small Intestinal Bacterial Overgrowth (SIBO) and Intestinal Methanogen Overgrowth (IMO). The following provides a comprehensive guide to the updates under…